Insider · CIK 0001737613

Lavelle Erin

Reports to the SEC for 5 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001737613

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34.8K sh	—	—	34,843
2026-04-30	AVLNAvalyn Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	26,978
2025-04-29	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,017
2023-06-08	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-10-31	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	COO & CFO	AAward	+170K sh	—	—	170,000
2022-05-12	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-01-27	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	COO & CFO	AAward	+170K sh	—	—	170,000
2019-10-22	ALDER BIOPHARMACEUTICALS INCA Award	Chief Operating Officer	AAward	+11.7K sh	—	—	16,092
2019-10-22	ALDER BIOPHARMACEUTICALS INCU Disposition from Tender	Chief Operating Officer	UDisposition from Tender	−16.1K sh	$18.00	−$290K	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−300K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−150K sh	—	—	0
2019-04-25	ALDER BIOPHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−1,434 sh	$13.67	−$19.6K	4,408
2019-04-23	ALDER BIOPHARMACEUTICALS INCA Award	Chief Operating Officer	AAward	+5,842 sh	—	—	5,842
2019-02-06	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+150K sh	—	—	150,000
2018-04-16	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Jun 114
Lavelle Erin0001193125-26-267708
SEC(opens sec.gov)
May 14
Lavelle Erin0001193125-26-201860
SEC(opens sec.gov)
May 14
Lavelle Erin0000950170-25-062119
SEC(opens sec.gov)
Jun 94
Lavelle Erin0001209191-23-035857
SEC(opens sec.gov)
Nov 24
Lavelle Erin0001209191-22-055404
SEC(opens sec.gov)
May 164
Lavelle Erin0001209191-22-029323
SEC(opens sec.gov)
Jan 314
Lavelle Erin0001209191-22-005659
SEC(opens sec.gov)
Oct 244
Lavelle Erin0001209191-19-053922
SEC(opens sec.gov)
Apr 254
Lavelle Erin0001209191-19-026034
SEC(opens sec.gov)
Feb 84
Lavelle Erin0001209191-19-008591
SEC(opens sec.gov)
Apr 184
Lavelle Erin0001209191-18-025410
SEC(opens sec.gov)

Companies

Address

C/O JADE BIOSCIENCES, INC. 221 CRESCENT ST., BLDG. 23, STE. 105

WALTHAM, MA, 02453